Expression of the cell surface proteoglycan glypican-5 is developmentally regulated in kidney, limb, and brain

Developmental Biology

Volumn 190, Issue 1, 1997, Pages 78-93

  Saunders, Scott ^a,b   Paine Saunders, Stephenie ^a   Lander, Arthur D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYPICAN; HEPARAN SULFATE; PROTEOGLYCAN;

ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; EXTRACELLULAR MATRIX; GENE MUTATION; GROWTH REGULATION; KIDNEY DEVELOPMENT; LIMB DEVELOPMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

EID: 0031259923     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1006/dbio.1997.8690     Document Type: Article

References (61)

1. Aviezer D., Yayon A. Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF. Proc. Natl. Acad. Sci. USA. 91:1994;12173-12177.
2. Bernfield M., Kokenyesi R., Kato M., Hinkes M. T., Spring J., Gallo R. L., Lose E. J. Biology of the syndecans: A family of transmembrane heparan sulfate proteoglycans. Annu. Rev. Cell Biol. 8:1992;365-393.
3. Bourdon M. A., Krusius T., Campbell S., Schwartz N. B., Ruoslahti E. Identification and synthesis of a recognition signal for the attachment of glycosaminoglycans to proteins. Proc. Natl. Acad. Sci. USA. 84:1987;3194-3198.
4. Brown S., Gersen S., Anyane-Yeboa K., Warburton D. Preliminary definition of a "critical region" of chromosome 13 in q32: Report of 13 new cases with 13q deletions and review of the literature. Am. J. Med. Genet. 45:1993;52-59.
5. Brown S., Russo J., Chitayat D., Warburton D. The 13q- syndrome: The molecular definition of a critical deletion region in the band 13q32. Am. J. Hum. Genet. 57:1995;859-866.
6. Chalazonitis A., Kalberg J., Twardzik D. R., Morrison R. S., Kessler J. A. Transforming growth factor beta has neurotrophic actions on sensory neuronsin vitro. Dev. Biol. 152:1995;121-132.
7. Cheifetz S., Massague J. The TGF-b receptor proteoglycan: Cell surface expression and ligand binding in the absence of glycosaminoglycan chains. J. Biol. Chem. 264:1989;12025-12028.
8. David G., Lories V., Decock B., Marynen P., Cassiman J.-J., Berghe H. V. d. Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts. J. Cell Biol. 111:1990;3165-3176.
9. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:1983;6-13.
10. Filmus J., Church J. G., Buick R. N. Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine. Mol. Cell Biol. 8:1988;4243-4249.
11. Filmus J., Shi W., Wong Z. M., Wong M. J. Identification of a new membrane-bound heparan sulfate proteoglycan. Biochem. J. 311:1995;561-565.
12. Fradkin L. G., Noordermeer J. N., Nusse R. TheDrosophila. Dev. Biol. 168:1995;202-213.
13. Gall C., Lauterborn J., Guthrie K. In situ hybridization:A sensitive measure of activity-dependent changes in neuronal gene expression. Autoradiography and Correlative Imaging. 1995;Academic Press, San Diego. p. 379-399.
14. Hammerman M. R. Growth factors in renal development. Semin. Nephrol. 15:1995;291-299.
15. Hammerman M. R., Rogers S. A., Ryan G. Growth factors and metanephrogenesis. Am. J. Physiol. 262:1992;F523-F532.
16. Herndon M. E., Lander A. D. A diverse set of developmentally regulated proteoglycans is expressed in the rat central nervous system. Neuron. 4:1990;949-961.
17. Herzlinger D., Qiao J., Cohen D., Ramakrishna N., Brown A. M. C. Induction of kidney epithelial morphogenesis by cells expressing Wnt-1. Dev. Biol. 166:1994;815-818.
18. Hudson T. e. a. An STS-based map of the human genome. Science. 270:1995;1945-1954.
19. Ivins J. K., Litwak E. D., Kumbasar A., Stipp C. S., Lander A. D. Cerebroglycan, a developmentally regulated cell-surface heparan sulfate proteoglycan, is expressed on developing axons and growth cones. Dev. Biol. 184:1997.
20. Iwasaki S., Hattori A., Sato M., Tsujimoto M., Kohno M. Characterization of the bone morphogenetic protein-2 as a neurotrophic factor. Induction of neuronal differentiation of PC12 cells in the absence of mitogen-activated protein kinase activation. J. Biol. Chem. 271:1996;17360-17365.
21. Jackson R. L., Busch S. J., Cardin A. D. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol. Rev. 71:1991;481-539.
22. Jackson S. M., Nakato H., Sugiura M., Jannuzi A., Oakes R., Kaluza V., Golden C., Selleck S. B. Division abnormally delayed, aDrosophila. Development. 1997.
23. Janknecht R., de Martynoff G., Lou J., Hipskind R. A., Nordheim A., Stunnenberg H. G. Rapid efficient purification of native histidine-tagged protein expressed by recombinant vaccinia virus. Proc. Natl. Acad. Sci. USA. 88:1991;8972-8976.
24. Kispert A., Vainio S., Shen L., Rowitch D. H., McMahon A. P. Proteoglycans are required for maintenance of Wnt-11 expression in the ureter tips. Development. 122:1996;3627-3637.
25. Kodukula K., Gerber L. D., Amthauer R., Brink L., Udenfriend S. Biosynthesis of glycosylphosphatidylinositol (gpi)-anchored membrane proteins in intact cells: Specific amino acid requirements adjacent to the site of cleavage and gpi attachment. J. Cell Biol. 120:1993;657-664.
26. Krusius T., Ruoslahti E. Primary structure of an extracellular matrix proteoglycan core protein deduced form cloned cDNA. Proc. Natl. Acad. Sci. USA. 83:1986;7683-7687.
27. Lander A. D. Proteoglycans in the nervous system. Curr. Opin. Neurobiol. 3:1993;716-723.
28. Lander A. D. Targeting the glycosaminoglycan-binding sites on proteins. Chem. Biol. 1:1994;73-78.
29. Linker A., Hovingh P. Heparinase and heparitinase from flavobacteria. Methods Enzymol. 28:1972;902-910.
30. Litwack E. D., Stipp C. S., Kumbasar A., Lander A. D. Neuronal expression of glypican, a cell-surface glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan, in the adult rat nervous system. J. Neurosci. 14:1994;3713-3724.
31. Martin P., Swanson G. J. Descriptive and experimental analysis of the epithelial remodellings that control semicircular canal formation in the developing mouse inner ear. Dev. Biol. 159:1993;549-558.
32. McFarlane S., McNeill L., Holt C. E. FGF signaling and target recognition in the developingXenopus. Neuron. 15:1995;1017-1028.
33. Mertens G., Van der Schueren B., van den Berghe H., David G. Heparan sulfate expression in polarized epithelial cells: the apical sorting of glypican (GPI-anchored proteoglycan) is inversely related its heparan sulfate content. J. Cell Biol. 132:1996;487-497.
34. Nakato H., Futch T. A., Selleck S. B. The division abnormally delated (dallyDrosophila. Development. 121:1995;3687.
35. Nielsen H., Engelbrecht J., Brunak S., von Heijne G. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng. 10:1997;1-6.
36. Perantoni A. O., Dove L. F., Karavanova I. Basic fibroblast growth factor can mediate the early inductive events in renal development. Proc. Natl. Acad. Sci. USA. 92:1995;4696-4700.
37. Pilia G., Hughes-Benzie R. M., MacKenzie A., Baybayan P., Chen E. Y., Huber R., Neri G., Cao A., Foarabosco A., Schlessinger D. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nature Genet. 12:1996;241-247.
38. Rapraeger A., Jalkenen M., Bernfield M. The cell surface proteoglycan from mouse mammary epithelial cells bears chondroitin sulfate and heparan sulfate glycosaminoglycans. J. Biol. Chem. 260:1985;11046-11052.
39. Rapraeger A., Krufka A., Olwin B. B. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science. 252:1991;1705-1708.
40. Reichsman F., Smith L., Cumberledge S. Glycosaminoglycans can modulate extracellular localization of the wingless protein and promote signal transduction. J. Cell Biol. 135:1996;819-827.
41. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
42. Saunders S., Jalkanen M., O'Farrell S., Bernfield M. Molecular cloning of syndecan, an integral membrane proteoglycan. J. Cell Biol. 108:1989;1547-1556.
43. Saunders S., Paine-Saunders S., Lander A. D. Glypican-5: Molecular cloning of a novel member of the glypican gene family. Mol. Biol. Cell. 7:1996.
44. Saxén L. Organogenesis of the Kidney. 1987;Cambridge Univ. Press, Cambridge.
45. Schlessinger J., Lax I., Lemmon M. Regulation of growth factor activation by proteoglycans: What is the role of the low affinity receptors? Cell. 83:1995;357-360.
46. Shworak N. W., Shirakawa M., Mulligan R. C., Rosenberg R. D. Characterization of ryudocan glycosaminoglycan acceptor sites. J. Biol. Chem. 269:1994a;21204-21214.
47. Spanakis E. Problems related to the interpretation of autoradiographic data on gene expression using common constitutive transcripts as controls. Nucleic Acids Res. 21:1993;3809-3819.
48. Spanakis E., Brouty-Boyé D. Evaluation of quantitative variation in gene expression. Nucleic Acids Res. 22:1994;799-806.
49. Stark K., Vainio S., Vassileva G., McMahon A. P. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature. 372:1994;679-683.
50. Steinfeld R., Van Den Berghe H., David G. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypicans. J. Cell Biol. 133:1996;405-416.
51. Stern D. F., Hare D. L., Cecchini M. A., Weinberg R. A. Construction of a novel oncogene based on synthetic sequences encoding epidermal growth factor. Science. 235:1987;321-324.
52. Stipp C. S., Litwack E. D., Lander A. D. Cerebroglycan: An integral membrane heparan sulfate proteoglycan that is unique to the developing nervous system and expressed specifically during neuronal differentiation. J. Cell Biol. 124:1994;149-160.
53. Unsicker K., Meier C., Krieglstein K., Sartor B. M., Flanders K. C. Expression, localization, and function of transforming growth factor-betas in embryonic chick spinal cord, hindbrain, and dorsal root ganglia. J. Neurobiol. 29:1996;162-276.
54. Veugelers M., Vermeesch J., Reekmans G., Steinfeld R., Marynen P., David G. Characterization of glypican-5 and chromosomal localization of human GPC5, a new member of the glypican gene family. Genomics. 40:1997;24-30.
55. Vogel K. G., Paulsson M., Heinegard D. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem. J. 223:1984;587-597.
56. Walter M. A., Spillett D. J., Thomas P., Weissenbach J., Goodfellow P. N. A method for constructing radiation hybrid maps of whole genomes. Nature Genet. 7:1994;22-28.
57. Watanabe K., Yamada H., Yamaguchi Y. K-glypican: A novel gpi-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney. J. Cell Biol. 130:1995;1207-1218.
58. Yayon A., Klagsbrun M., Esko J. D., Leder P., Ornitz D. M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell. 64:1991;841-848.
59. Zhang L., David G., Esko J. D. Repetitive Ser-Gly sequences enhance heparan sulfate assembly in proteoglycans. J. Biol. Chem. 270:1995;27127-27135.
60. Zhang L., Esko J. D. Amino acid determinants that drive heparan sulfate assembly in a proteoglycan. J. Biol. Chem. 269:1994;19295-19299.
61. Zioncheck T. F., Richardson L., Liu J., Chang L., King K. L., Bennett G. L., Fugedi P., Chamow S. M., Schwall R. H., Stack R. J. Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity. J. Biol. Chem. 270:1995;16871-16878.